Miscarried research center - clinician (2023)

Professor Arri Coomarasamy, Universität Birmingham

Professor Arri Coomarasamy is the director of the National Center for miscarriage of Tommy.

Professor Coomarasamy heads a research group at the head of early pregnancy treatment, reproductive medicine and the health of the global women. Portfolio includes numerous national and international multicenter randomized controlled studies, including the promise study (the role of progesterone in women with inexplicable recurring miscarriages) thatTablet study (levothyroxine therapy for women with thyroid antibodies), the PrisM study (progesterone therapy for women with the bleeding of early pregnancy), the reaction study (G -CSF treatment for recurring miscarriage), the Aims study (the effects of prophylactic antibioticsBefore a miscarriage in countries with low income) and the WHO champion attempt (the role of Carbetocin to prevent the bleeding). He has Veröf Veröfpublicly.

Professor Coomarasamy serves or has worked in several international and national committees in the past, including the BJOG editorial committee, the RCOG well -being of women's research, various WHO committees, the group of early pregnancy Clinical studies, the group of reproductive Medicine Clinical Studies Groupand the grouping committee. He is a foundation recent from Ammalife, a charity organized by Great Britain with the global mission, to reduce the deaths of mothers in countries with low incomes.

Dr.Manjeet Shehmar, University of Birmingham

Dr.Manjeet Shehmar is a consultant for obstetrics and gynecology and clinical director of gyling in Birmingham Women's Hospital. In addition, she was the clinical leadership for the early pregnancy department and member of the Executive Committee of the UK Association of Early pregnancy units (Aepu). She is clinical as part of the earlyPregnancy teams actively and leads specialists -Scan clinics that are devoted to early pregnancy and acute gynecology. During their time in Birmingham Women's Hospital, she has now led the growth of the early pregnancy unit with specialist advisors and caregivers. They are an advanced trainer for early pregnancy problemsBoth for medical and nursing staff and has a higher degree in medical training. You have experience in researching medical training and patient experience in gynecology with over 20 original items that are in leading timeWritings and five chapters were published in academic books. They were recognized nationally for their innovative service developments in early pregnancy by being the finalist and highly praised at Two Health Service Journal Awards.

Professor Phillip Bennett, Imperial College, London

Professor Phillip Bennett is the director of the Institute for reproductive and developmental biology at Imperial College, one of the largest health research institutions for women in Europe. He is also in the imperial NHS research director for women and child health as well as clinical academic training in obstetrics and gynecology.International reputation for research into pregnancy complications and a success story over thirty years to improve the health of pregnant women and their babies through basic science and translational research and apply these results to clinical practice. He has both laboratory and clinical research techniques in a numberApplied by birth areas, including miscarriage, prenatal diagnosis, growth restriction of fetal growth and premature birth. He supervised postgraduate research of thirty -two doctoral students and extensively worked with the industryEt to carry out basic science and clinical phase studies with new drugs for the prevention or treatment of pregnancy complications. It keeps patents on methods for predicting and prevention of premature birth., British, European and Italian magazines for obstetrics and gynecology.

Professor Lesley Regan, Imperial College, London

Professor Regan is the director of the recurrent misfiring service at St. Mary's, a multidisciplinary team that she has developed to carry out extensive studies and treatment for couples with recurring early and late miscarriages.Year receives year and, at their subsequent pregnancies, continues to enable many thousands of other couples before a prenatal care.

As the elected President of the RCOG since 2016, Professor Regan plays a leading role in the national and international further development of women's health interests. She is also a president of the UK Association of Early pregnancy and chair of the sexual and reproductive legal committee for women.Committee and professional member of the human committees of fertilization and embryology authority and the research license. She is a trustee for the well -being of women (WOW), the national confidential investigation of the patient results and death (NCEPOD), the Genesis Trust and Charm - the charity organization forResearch into miscarriages. Professor Regan has also published two successful books on miscarriage and pregnancy for the layperson public and presented a number of 6 BBC horizon documentary films.

Professor Tom Bourne, Imperial College, London

Professor Tom Bourne is an extraordinary professor and research team leader at Imperial College London and consultant Gynecologist at Queen Charlotte and Chelsea Hospital London. He visits Professor and consultant at KU Leuven in Belgium. He has a special interest in the treatment of early pregnancy complications and the use of ultrasoundthe evaluation of gynecological disorders. Your research has changed the national guidelines for the care of women with miscarriage and other gynecological disorders in the UK and internationally. He has published a lot about all aspects of diagnosis and treatment of most complications of early pregnancyA significant media interest in the UK and internationally.

He edited six books, published over 300 articles in international magazines and invited to speak and speak on numerous international meetings on topics in relation to the early pregnancy and the use of ultrasound and diagnostics in gynecology. He has an H-indexFrom 62 with Google Scholar. He is a member of the scientific committee and was recently elected treasurer of the Executive Committee of the International Society for Ultrasound in Obstetrics and Gynecology (ISUOG) after he has been on the board for 8 years. He is a medical consultant and trusteePatient group, the fallopian pregnancy trust.He was a specialist advisor for her guideline for pain and bleeding in the early pregnancy. He is a member of the steering committee of the International Ovarial Tumor Analysis (IOTA) and the International Endometrium -Tumor Analysis (IETA) studies, both of the large multiple -centers -Studies are. He was a member of the consensus committee of the Society of Radiologists in Ultrasound (SRU) in the USA to develop secure guidelines for diagnosis of miscarriages in 2012, which led to an important consensus paper in New England Journal of Medicine. He was at the AmericanInstitute of Ultrasound in Medicine (Aium) consensus panel to create guidelines for the diagnosis of ovarian pathology in 2014.In 2015 he became one of the few British clinicians who were voted honorary ”of the Aium.Gynecologists. Your current main research interests relate to ultrasound, biomarker and translational research in early pregnancy as well as to the classification of ovarian tumors.

Professor Siobhan Quenby, University of Warwick

Professor Siobhan Quenby is a professor of obstetrics and honorary consultants at university clinics Coventry and Warwickshire and the University of Warwick. She is the director of the locally financed biomedical research unit for reproductive health.Dedication of a recurrent loss of pregnancy. They have more than twenty years of experience in researching implantation and recurring miscarriage and has published over 125 original items and 22 chapters for academic books.Association of early pregnancy, chair of the RCOG group of clinical studies in early pregnancy and member of the MHRA expert advice member for women for women's health.at is financed by Tommy, Nihr, UHCW and other medical charity organizations.

Professor Jan Brosens, University of Warwick

Professor Jan Brosens's research research focuses on the role of the signal transmission of the steroid hormone in the human endometrium, especially in connection with prevailing reproduction disorders such as infertility,Endometriosisand endometrium cancer. Main interest focuses on improving the treatment of miscarriages, the most common complication of pregnancy. He received his doctorate in 1999 at the University of London and worked on the mechanisms on which the manufacture of the outline of the womb (endometrium) is based on pregnancy, A process called decentialization. He received a scholarship for clinical scientists from Wellcome Trust in 1998, changed in 2004 as chairman of the reproductive sciences and became chairman of reproductive medicine in 2008.In May 2011 he was appointed chairman of obstetrics and gynecology at the University of Warwick. Professor Brosens is also deputy head of the Department of Biomedical Sciences at the Warwick Medical School.